NANOG and hepatocellular carcinoma: And Chen et al. reported YAP1 as an important mediator of TLR4/NANOG oncogenic pathway in maintaining the tumor-initiating stem-like cells (TICs) population by suppression of cytostatic TGF-β signaling in HCC [32].